Literature DB >> 17438029

T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.

Masako Andoh1, Guoquan Zhang, Kasi E Russell-Lodrigue, Heather R Shive, Brad R Weeks, James E Samuel.   

Abstract

Coxiella burnetii, the etiological agent of Q fever, has two phase variants. Phase I has a complete lipopolysaccharide (LPS), is highly virulent, and causes Q fever in humans and pathology in experimental animals. Phase II lacks an LPS O side chain, is avirulent, and does not grow well in immunocompetent animals. To understand the pathogenicity of Q fever, we investigated the roles of immune components in animals infected with Nine Mile phase I (NM I) or Nine Mile phase II (NM II) bacteria. Immunodeficient mice, including SCID mice (deficient in T and B cells), SCIDbg mice (deficient in T, B, and NK cells), nude mice (deficient in T cells), muMT mice (deficient in B cells), bg mice (deficient in NK cells), mice deficient in tumor necrosis factor alpha (TNF-alpha(-/-) mice), and mice deficient in gamma interferon (IFN-gamma(-/-) mice), were compared for their responses to infection. SCID, SCIDbg, nude, and IFN-gamma(-/-) mice showed high susceptibility to NM I, and TNF-alpha(-/-) mice showed modest susceptibility. Disease caused by NM I in SCID, SCIDbg, and nude mice progressed slowly, while disease in IFN-gamma(-/-) and TNF-alpha(-/-) mice advanced rapidly. B- and NK-cell deficiencies did not enhance clinical disease development or alter bacterial clearance but did increase the severity of histopathological changes, particularly in the absence of B cells. Mice infected with NM II showed no apparent clinical disease, but T-cell-deficient mice had histopathological changes. These results suggest that T cells are critical for clearance of C. burnetii, either NM I or NM II, that IFN-gamma and TNF-alpha are essential for the early control of infection, and that B cells are important for the prevention of tissue damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438029      PMCID: PMC1932934          DOI: 10.1128/IAI.01767-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF.

Authors:  J Dellacasagrande; C Capo; D Raoult; J L Mege
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

Review 2.  To stick or not to stick: the new leukocyte homing paradigm.

Authors:  D Dunon; L Piali; B A Imhof
Journal:  Curr Opin Cell Biol       Date:  1996-10       Impact factor: 8.382

Review 3.  Q fever.

Authors:  D Raoult; T Marrie
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

4.  The nude mutation results in impaired primary antibody repertoire.

Authors:  A Kaushik; G Kelsoe; J C Jaton
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

5.  Comparison of virulence for guinea pigs and mice of different Coxiella burnetii phase I strains.

Authors:  J Kazár; M Lesý; P Propper; D Valková; R Brezina
Journal:  Acta Virol       Date:  1993-12       Impact factor: 1.162

6.  Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.

Authors:  H C Hänsch; D A Smith; M E Mielke; H Hahn; G J Bancroft; S Ehlers
Journal:  Int Immunol       Date:  1996-08       Impact factor: 4.823

Review 7.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

8.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.

Authors:  A C Issekutz; T B Issekutz
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

10.  Valvular endocarditis occurs as a part of a disseminated Coxiella burnetii infection in immunocompromised BALB/cJ (H-2d) mice infected with the nine mile isolate of C. burnetii.

Authors:  E Atzpodien; W Baumgärtner; A Artelt; D Thiele
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

View more
  70 in total

1.  Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.

Authors:  Amanda J Read; Sara Erickson; Allen G Harmsen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

2.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

3.  Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.

Authors:  Laura Buttrum; Lindsey Ledbetter; Rama Cherla; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

5.  Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella.

Authors:  Paul A Beare; Nathan Unsworth; Masako Andoh; Daniel E Voth; Anders Omsland; Stacey D Gilk; Kelly P Williams; Bruno W Sobral; John J Kupko; Stephen F Porcella; James E Samuel; Robert A Heinzen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 6.  Animal models of Q fever (Coxiella burnetii).

Authors:  Kevin R Bewley
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

7.  The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Authors:  Aminul Islam; Michelle Lockhart; John Stenos; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2013-08-19       Impact factor: 2.345

8.  Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii.

Authors:  Joseph G Graham; Caylin G Winchell; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 10.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.